Reuters logo
2 个月内
BRIEF-Inovio begins phase 3 clinical trial of VGX-3100
2017年6月8日 / 上午10点14分 / 2 个月内

BRIEF-Inovio begins phase 3 clinical trial of VGX-3100

1 分钟阅读

June 8 (Reuters) - Inovio Pharmaceuticals Inc

* Inovio begins phase 3 clinical trial of VGX-3100 for the treatment of HPV-related cervical pre-cancer

* Plans to immediately begin recruiting patients for phase 3 trial

* Pivotal data from program will support potential licensure of VGX-3100 as first immunotherapy for this disease​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below